Blend70 mg
GLOW Recovery Blend (70 mg Vial)
Dosing & reconstitution protocol
Quick Reference
VIAL SIZE70 mg (GHK-Cu 50 mg + TB-500 10 mg + BPC-157 10 mg)
RECONSTITUTION3.0 mL bacteriostatic water
CONCENTRATION23.3 mg/mL total
ROUTESubcutaneous injection
FREQUENCYOnce daily
CYCLE LENGTH4 weeks on / 2–4 weeks off
DOSE RANGE2,330 mcg (2.33 mg) total daily — 10 units (0.10 mL)
STORAGE−20 °C lyophilized / 2–8 °C reconstituted (use within 4 weeks)
Overview
GLOW combines GHK-Cu (50 mg), TB-500 (10 mg), and BPC-157 (10 mg). Each 0.10 mL delivers ~1.7 mg GHK-Cu + ~0.33 mg TB-500 + ~0.33 mg BPC-157. Use 30-unit or 50-unit insulin syringes for accuracy.
Dosing & Reconstitution Guide
| Phase | Daily Dose | Units | Volume |
|---|---|---|---|
| Weeks 1–4 | 2,330 mcg (2.33 mg) total | 10 units | 0.10 mL |
Reconstitution Instructions
1.
Draw 3.0 mL bacteriostatic water with a sterile syringe.
2.
Inject slowly down the vial wall; avoid foaming.
3.
Gently swirl/roll until dissolved (do not shake).
4.
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 4 weeks.
This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
- ✓GLOW Blend Vials (70 mg): 1 vial
- ✓Insulin Syringes (30-unit or 50-unit): 28 syringes
- ✓Bacteriostatic Water (10 mL): 1 bottle
- ✓Alcohol Swabs: 56 swabs
Dosing Protocol
Schedule
Once daily subcutaneously.
Cycle Structure
4 weeks on / 2–4 weeks off.
Timing
Any consistent time daily. Use 30-unit or 50-unit insulin syringes for accuracy.
Storage & Handling
- ✓Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
- ✓Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
- ✓Allow vials to reach room temperature before opening to reduce condensation uptake.
- ✓Do not freeze reconstituted solution.
- ✓Faint blue tint after reconstitution is normal (from GHK-Cu component).
Important Notes
- ✓All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.
- ✓Use new sterile insulin syringes for each injection; dispose in a sharps container.
- ✓Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
- ✓Inject slowly; wait a few seconds before withdrawing the needle.
- ✓Document daily dose and site rotation to maintain consistency.